The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Aerovate Therapeutics, Inc. Common Stock 008064107 56,894 3,103,879 SH   SOLE   3,103,879 0 0
Akero Therapeutics, Inc. Common Stock 00973Y108 31,676 2,232,251 SH   SOLE   2,232,251 0 0
AvroBio, Inc. Common Stock 05455M100 5,968 4,520,863 SH   SOLE   4,520,863 0 0
Cogent Biosciences, Inc. Common Stock 19240Q201 1,397 186,487 SH   SOLE   186,487 0 0
Day One Biopharmaceuticals, Inc. Common Stock 23954D109 81,360 8,201,638 SH   SOLE   8,201,638 0 0
Dyne Therapeutics, Inc. Common Stock 26818M108 86,132 8,934,902 SH   SOLE   8,934,902 0 0
F-star Therapeutics, Inc. Common Stock 30315R107 2,128 599,524 SH   SOLE   599,524 0 0
Gemini Therapeutics, Inc. Common Stock 36870G105 7,304 5,254,365 SH   SOLE   5,254,365 0 0
Generation Bio, Co. Common Stock 37148K100 60,767 8,278,876 SH   SOLE   8,278,876 0 0
Ikena Oncology, Inc. Common Stock 45175G108 30,611 5,018,178 SH   SOLE   5,018,178 0 0
Kymera Therapeutics, Inc. Common Stock 501575104 290,980 6,875,698 SH   SOLE   6,875,698 0 0
Magenta Therapeutics, Inc. Common Stock 55910K108 10,082 3,476,536 SH   SOLE   3,476,536 0 0
Replimune Group, Inc. Common Stock 76029N106 54,499 3,209,627 SH   SOLE   3,209,627 0 0
Spero Therapeutics, Inc. Common Stock 84833T103 8,971 1,031,160 SH   SOLE   1,031,160 0 0
Vigil Neuroscience, Inc. Common Stock 92673K108 41,033 5,836,874 SH   SOLE   5,836,874 0 0
Viridian Therapeutics, Inc. Common Stock 92790C104 1,665 90,072 SH   SOLE   90,072 0 0
Xilio Therapeutics, Inc. Common Stock 98422T100 19,509 2,759,344 SH   SOLE   2,759,344 0 0